Jacopo Polvere

Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine

A. Ciabattini, D. Medaglini, S. Lucchesi, 2023, Cells.

Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine

A. Ciabattini, D. Medaglini, S. Lucchesi, 2021, Frontiers in Immunology.

B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV

A. Ciabattini, D. Medaglini, S. Lucchesi, 2023, Communications Medicine.

The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients

A. Ciabattini, D. Medaglini, G. Pastore, 2022, Frontiers in Immunology.

A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses

A. Ciabattini, D. Medaglini, S. Lucchesi, 2022, Blood Advances.

The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose

A. Ciabattini, D. Medaglini, G. Pastore, 2021, medRxiv.

Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine

A. Ciabattini, D. Medaglini, S. Lucchesi, 2021, medRxiv.

Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a machine learning approach

M. Augello, D. Medaglini, Giorgio Montesi, 2024, Journal of translational medicine.